FDA adds rare vision-loss warning to Ozempic, Wegovy and all GLP-1 drugs
The FDA says all GLP-1 drugs will carry a warning about NAION, a rare eye condition that can cause permanent vision loss.
The FDA says all GLP-1 drugs will carry a warning about NAION, a rare eye condition that can cause permanent vision loss.